TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Euroform MediPharm AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,483
|
2,875
|
3,217 |
| Financial expenses |
0
|
0
|
11 |
| Earnings before taxes |
-209
|
44
|
-317 |
| EBITDA |
-171
|
98
|
-231 |
| Total assets |
1,786
|
2,176
|
2,225 |
| Current assets |
1,544
|
1,928
|
1,931 |
| Current liabilities |
490
|
854
|
845 |
| Equity capital |
1,282
|
1,307
|
1,349 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
11
|
13
|
13 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
71.8%
|
60.1%
|
60.6% |
| Turnover per employee |
226
|
221
|
247 |
| Profit as a percentage of turnover |
-8.4%
|
1.5%
|
-9.9% |
| Return on assets (ROA) |
-11.7%
|
2.0%
|
-13.8% |
| Current ratio |
315.1%
|
225.8%
|
228.5% |
| Return on equity (ROE) |
-16.3%
|
3.4%
|
-23.5% |
| Change turnover |
-294
|
-352
|
17 |
| Change turnover % |
-11%
|
-11%
|
1% |
| Chg. No. of employees |
-2
|
0
|
1 |
| Chg. No. of employees % |
-15%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.